To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults

Clinical trial NCT01750814 · COMPLETED

Trial details

NCT number: NCT01750814
Sponsor: Green Cross Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prophylaxis Against Influenza

Start date: 2013-06-01
Primary completion: 2013-07-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.